SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The SPY is experiencing heightened volatility as market participants navigate intensifying geopolitical tensions, particularly surrounding the ongoing conflict in Iran. The community is deeply divided, with many debating the impact of potential ground troop deployments, the reliability of official diplomatic updates, and whether to hold positions through the weekend amid the uncertainty.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors debate whether the stock is a value-based buying opportunity or a struggling asset amid uncertainty surrounding upcoming Medicare Advantage reimbursement rates and regulatory pressures. The community remains divided, with some betting on a turnaround fueled by AI-driven cost optimizations, while others fear further downside if pending government decisions fail to meet market expectations.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor attention driven by its strategic pivot into domestic pharmaceutical manufacturing and advanced materials, with the community actively speculating on the potential for government contracts and a major corporate revaluation. Market participants are closely monitoring the company's strengthened balance sheet and potential takeover prospects, while ongoing discussions frequently highlight the stock's role as a play on U.S. supply chain independence.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors weigh strong earnings performance and consistent guidance raises against the broader volatility in the software sector. The community is actively debating the company's competitive position against legacy players like The Trade Desk, with many bulls pointing to recent AI product launches and institutional accumulation as primary catalysts for a potential rebound.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing heightened activity following reports that the company is exploring a sale of its China business, which could potentially value the unit at over $1 billion. Community members are actively debating the impact of this potential divestment on the balance sheet while keeping a close eye on technical support levels and high short interest.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is trending as the company issued a vigorous, data-backed rebuttal against a short-seller report, providing evidence to refute allegations of channel stuffing and business malpractice. Investors are actively debating the long-term outlook, with many expressing strong confidence in management's growth strategy and share buybacks while closely monitoring institutional support and the stock's volume.

Pelican Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2024 and is headquartered in New York, NY.

Greenland Energy Co.

Greenland Energy is trending following its recent SPAC merger and Nasdaq debut, sparking intense debate over whether it represents a generational oil opportunity or a speculative scam. Community discussion is polarized between optimistic bulls highlighting the company's access to 13 billion barrels of potential oil reserves and skeptical traders warning of high volatility and inherent risks associated with early-stage resource exploration.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Investors are actively weighing the impact of escalating Middle East tensions and shifting energy policies against historically high market valuations. Amid these macroeconomic uncertainties, community sentiment remains sharply polarized between those rotating into defensive positions or cash and those aggressively adding to their long-term positions in major ETFs like VOO to capitalize on current volatility.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp (CCL) is facing downward pressure as investors weigh strong record bookings and operational performance against concerns regarding elevated fuel costs and geopolitical tensions in the Middle East. The community is sharply divided, with many long-term holders viewing the current dip as a significant buying opportunity, while others remain cautious, debating the potential for further volatility driven by macro-economic factors.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is facing intense downward pressure and significant volatility, fueled by deep-seated anxiety over the escalating Iran conflict and its potential to disrupt global supply chains and energy markets. Community sentiment is largely characterized by a breakdown in trust regarding current geopolitical management, with investors actively debating whether to capitulate or wait for a potential, albeit elusive, weekend peace catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanguard Announces Share Splits for Five Equity Index ETFs

Vanguard Announces Share Splits for Five Equity Index ETFs Vanguard Announces Share Splits for Five Equity Index ETFs PR Newswire VALLEY FORGE, Pa., March 24, 2026 VALLEY FORGE, Pa., March 24, 2026...

Should Vanguard S&P 500 Growth Index Fund ETF Shares (VOOG) Be on Your Investing Radar?

<ul class="summary-bullets"><li>Patients treated with povetacicept also demonstrated a 77.4% reduction from baseline in serum galactose deficient IgA1, a critical, disease-specific biomarker for IgA nephropathy, the company added.</li><li>Vertex now expects to complete necessary submissions seeking approval for povetacicept in IgA Nephropathy by March.</li><li>The company has a priority review voucher which would allow it to reduce the review time from ten months to six, it added.</li></ul><p><br>Shares of Vertex Pharmaceuticals Incorporated (VRTX) rose as much as 7% after hours on Monday after the company announced positive 36-week data from its ongoing late-stage trial evaluating povetacicept in immunoglobulin A nephropathy.</p><p>IgA nephropathy or Berger’s disease is an autoimmune kidney disease occurring when immunoglobulin A (IgA) antibody clumps deposit in the kidney’s glomeruli, causing inflammation and damage.</p><h2 class="st-heading-2">Trial Takeaways</h2><p>The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-positive-week-36-interim-analysis-results">said</a> that patients treated with povetacicept on top of standard of care achieved a 52% reduction from baseline in urine protein to creatinine ratio at week 36, meeting the study’s key goal. The reduction was consistent across subgroups, the company said. &nbsp;</p><p>Patients treated with povetacicept also demonstrated a 77.4% reduction from baseline in serum galactose deficient IgA1, a critical, disease-specific biomarker for IgA nephropathy, the company added.</p><p>Povetacicept was generally safe and well tolerated with a majority of adverse events (AEs) being mild to moderate. There were no serious adverse events or deaths, and no discontinuations due to infections, the company added.</p><h2 class="st-heading-2">Plans Ahead</h2><p>Vertex now expects to complete necessary submissions seeking approval for povetacicept in IgA Nephropathy by March. The company has a priority review voucher which would allow it to reduce the review time from ten months to six, it added.</p><p>If approved, the company expects to launch povetacicept in a low volume subcutaneous auto-injector delivered once every four weeks via at-home administration.</p><p>Other companies with FDA-approved drugs for IgA Nephropathy include Travere Therapeutics and Novartis.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around VRTX shares stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.</p><p><a href="https://stocktwits.com/symbol/VRTX">VRTX stock</a> has declined 8% over the past 12 months.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/voyg-shares-decline-on-double-q4-miss-despite-record-2025-backlog/cZdVUXLRIeI">VOYG Shares Decline On Double Q4 Miss Despite Record 2025 Backlog</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, Vertex Pharmaceuticals' logo is displayed on a smartphone screen in front of a stock chart. (Photo illustration by Cheng Xin/Getty Images)

VRTX Soars In Extended Hours After Experimental Drug Shows Positive Changes In Autoimmune Kidney Disease

The company said that patients treated with povetacicept achieved a 52.0% reduction from baseline in urine protein to creatinine ratio at week 36, meeting the study’s key goal.

Equity

Should Vanguard S&P 500 Growth ETF (VOOG) Be on Your Investing Radar?

Growth ETF (VOOG) Hits New 52-Week High

VOOG hits a 52-week high amid tech-driven momentum and optimism over Fed rate cuts, hinting at more upside ahead.

Less-Than-Expected Inflation in July: Growth ETFs to Gain?

CPI rose less than expected, boosting hopes for Fed rate cuts and sparking interest in top growth-focused ETFs like VUG and RPG.



Three Rate Cuts Expected in 2025? ETFs in Focus 

Fed officials signal possible rate cuts this year, boosting the appeal of growth-focused ETFs amid slowing labor market trends. Tap ETFs like VUG, RPG and VOOG.

Fed to Cut Rates Ahead? Growth ETFs to Play 

Weak hiring and rising jobless rates have San Francisco Fed President Mary Daly eyeing Fed rate cuts. If the Fed cuts rates soon, growth ETFs like RPG and IVW could benefit.

Growth ETFs Set New Records, Brush Off Tariff Headwinds

Growth ETFs like MGK, VUG, IWY, IUSG, and SPYG and others hit fresh highs as investors shrug off tariff threats and chase AI-fueled momentum.


Vanguard Admiral Funds - Vanguard S&P 500 Growth ETF

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

VOOG
Vanguard S&P 500 Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VOOG News

VOOGVanguard S&P 500 Growth ETF